New York · 2025 Regular Session · Bill

S 6422: Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

In committee Last action March 13, 2025: REFERRED TO HIGHER EDUCATION

Plain-language summary

S 6422 is a bill introduced in the New York Senate on March 13, 2025. According to its official title, it concerns: Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy. Primary sponsor: Brad Hoylman-Sigal. It lists 1 additional sponsor. Most recent recorded action (March 13, 2025): REFERRED TO HIGHER EDUCATION.

Sponsors

Primary sponsor: Brad Hoylman-Sigal. 1 co-sponsor.